Reconceptualising treatment-resistant depression as difficult-to-treat depression
R. Hamish McAllister‐Williams(Cumbria Northumberland Tyne and Wear NHS Foundation Trust), A. John Rush(The University of Texas Southwestern Medical Center), Koen Demyttenaere(University Psychiatric Hospital), Philip Gorwood(Inserm), Siegfried Kasper(Medical University of Vienna), Afzal Javed(Nia Association), Peter Falkai(Ludwig-Maximilians-Universität München), Allan H. Young(King's College London), Malcolm Hopwood(The University of Melbourne), Eduard Vieta(Hospital Clínic de Barcelona), Ανδρέας Παπαδόπουλος(University of West Attica), Pierre Blier(Université du Québec à Rimouski), Jair C. Soares(The University of Texas Health Science Center at Houston), Celso Arango(Hospital Universitario La Paz)
Cited by 30
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k